Letter to the Editor

Split Viewer

Blood Res 2014; 49(2):

Published online June 25, 2014

https://doi.org/10.5045/br.2014.49.2.132

© The Korean Society of Hematology

A case of myelodysplastic syndrome with a der(1;18)(q10;q10) translocation

Jung-Sook Ha*, and Dong-Suk Jeon

Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.

Correspondence to : Correspondence to Jung-Sook Ha. Department of Laboratory Medicine, Keimyung University School of Medicine, 56, Dalsung-ro, Joong-gu, Daegu 700-712, Korea. ksksmom@dsmc.or.kr

Received: February 13, 2014; Revised: March 4, 2014; Accepted: May 15, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fig. 1.

(A) A nuclear-budding and megalocytic orthonormoblast representing dyserythropoiesis (Wright stain, ×1,000). (B) G-banded karyogram of bone marrow cells. The arrow indicates the der(1;18)(q10;q10) chromosome.


Table. 1.

Table 1 Reported cases with the der(1;18)(q10;q10) chromosomal abnormality.

Abbreviations: RAEB, refractory anemia with excess blasts; MPD, myeloproliferative disorder; ET, essential thrombocythemia; MDS-U, myelodysplastic syndrome, unclassifiable.


  1. Adeyinka, A, Wei, S, Sanchez, J. Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies. Cancer Genet Cytogenet, 2007;173;136-143.
    Pubmed
  2. Azuma, T, Yamanouchi, J, Inoue, K, et al. Derivative (1;18)(q10;q10) in essential thrombocythemia. Cancer Genet Cytogenet, 2010;199;62-64.
    Pubmed
  3. Wan, TS, Ma, SK, Au, WY, Chan, LC. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders. Cancer Genet Cytogenet, 2001;128;35-38.
    Pubmed
  4. Hussein, K, Huang, J, Lasho, T, et al. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis. Eur J Haematol, 2009;82;255-259.
    Pubmed
  5. Gangat, N, Strand, J, Lasho, TL, et al. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates. Eur J Haematol, 2008;80;197-200.
    Pubmed
  6. Diez-Martin, JL, Graham, DL, Petitt, RM, Dewald, GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc, 1991;66;287-299.
    Pubmed
  7. Rowley, JD. Abnormalities of chromosome 1 in myeloproliferative disorders. Cancer, 1975;36;1748-1757.
    Pubmed
  8. Addou-Klouche, L, Adelaide, J, Finetti, P, et al. Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer, 2010;9;213.
    Pubmed
  9. Caramazza, D, Hussein, K, Siragusa, S, et al. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. Eur J Haematol, 2010;84;191-200.
    Pubmed
  10. Hsiao, HH, Ito, Y, Sashida, G, Ohyashiki, JH, Ohyashiki, K. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia. Leuk Res, 2005;29;1247-1252.
    Pubmed
  11. Michaux, L, Wlodarska, I, Vellosa, ER, et al. Translocation (Y;1)(q12;q12) in hematologic malignancies. Report on two new cases, FISH characterization, and review of the literature. Cancer Genet Cytogenet, 1996;86;35-38.
    Pubmed

Article

Letter to the Editor

Blood Res 2014; 49(2): 132-134

Published online June 25, 2014 https://doi.org/10.5045/br.2014.49.2.132

Copyright © The Korean Society of Hematology.

A case of myelodysplastic syndrome with a der(1;18)(q10;q10) translocation

Jung-Sook Ha*, and Dong-Suk Jeon

Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.

Correspondence to: Correspondence to Jung-Sook Ha. Department of Laboratory Medicine, Keimyung University School of Medicine, 56, Dalsung-ro, Joong-gu, Daegu 700-712, Korea. ksksmom@dsmc.or.kr

Received: February 13, 2014; Revised: March 4, 2014; Accepted: May 15, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Fig 1.

    Figure 1.

    (A) A nuclear-budding and megalocytic orthonormoblast representing dyserythropoiesis (Wright stain, ×1,000). (B) G-banded karyogram of bone marrow cells. The arrow indicates the der(1;18)(q10;q10) chromosome.

    Blood Research 2014; 49: 132-134https://doi.org/10.5045/br.2014.49.2.132

    Table 1 . Reported cases with the der(1;18)(q10;q10) chromosomal abnormality..

    Abbreviations: RAEB, refractory anemia with excess blasts; MPD, myeloproliferative disorder; ET, essential thrombocythemia; MDS-U, myelodysplastic syndrome, unclassifiable..


    References

    1. Adeyinka, A, Wei, S, Sanchez, J. Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies. Cancer Genet Cytogenet, 2007;173;136-143.
      Pubmed
    2. Azuma, T, Yamanouchi, J, Inoue, K, et al. Derivative (1;18)(q10;q10) in essential thrombocythemia. Cancer Genet Cytogenet, 2010;199;62-64.
      Pubmed
    3. Wan, TS, Ma, SK, Au, WY, Chan, LC. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders. Cancer Genet Cytogenet, 2001;128;35-38.
      Pubmed
    4. Hussein, K, Huang, J, Lasho, T, et al. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis. Eur J Haematol, 2009;82;255-259.
      Pubmed
    5. Gangat, N, Strand, J, Lasho, TL, et al. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates. Eur J Haematol, 2008;80;197-200.
      Pubmed
    6. Diez-Martin, JL, Graham, DL, Petitt, RM, Dewald, GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc, 1991;66;287-299.
      Pubmed
    7. Rowley, JD. Abnormalities of chromosome 1 in myeloproliferative disorders. Cancer, 1975;36;1748-1757.
      Pubmed
    8. Addou-Klouche, L, Adelaide, J, Finetti, P, et al. Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer, 2010;9;213.
      Pubmed
    9. Caramazza, D, Hussein, K, Siragusa, S, et al. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. Eur J Haematol, 2010;84;191-200.
      Pubmed
    10. Hsiao, HH, Ito, Y, Sashida, G, Ohyashiki, JH, Ohyashiki, K. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia. Leuk Res, 2005;29;1247-1252.
      Pubmed
    11. Michaux, L, Wlodarska, I, Vellosa, ER, et al. Translocation (Y;1)(q12;q12) in hematologic malignancies. Report on two new cases, FISH characterization, and review of the literature. Cancer Genet Cytogenet, 1996;86;35-38.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download